MEDICAIDS PAKISTAN products and prices in Pakistan
Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.
Follow price changes 🔒 Company report (Pharma Pro)Private pharmaceutical manufacturer · Karachi · Pakistan
Karachi pharmaceutical manufacturer established in 1970 with oral, liquid and injectable manufacturing capabilities.
MEDICAIDS PAKISTAN products in Pakistan
MEDICAIDS PAKISTAN PVT LTD has 70 medicine presentations registered in Pakistan under 32 brands, covering 30 generic medicines. Most of its products are in Anti-infectives, CNS & mental health and Vitamins, minerals & nutrition. Its brands with the most registered strengths and packs are Resdal (Risperidone), CEFUROX (Cefuroxime), ECOCEF (Ceftriaxone) and CEVOCIP (Ciprofloxacin). 70 products have an official DRAP price on MedInfoBase. See all 32 brands A to Z
What is sourced, and how recent is it?
Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.
Company profile
- Legal / official name
- Medicaids Pakistan (Pvt.) Ltd.
- Company type
- Private pharmaceutical manufacturer
- Address
- Plot No. 10, Sector 27, Korangi Industrial Area, Karachi 74900, Pakistan · 74900
- Website
- medicaids.com.pk ↗
- Phone
- +92 21 35051960-61; +92 301 5177033
- Official contact
- Contact page ↗
- Corporate source details checked
- 16 Aug 2026
- Corporate profile completeness
- 100%
Company location
A sourced company location is recorded. Use the map link below for directions.
Portfolio at a glance
RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.
PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.
IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.
Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.
Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.
Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.
How complete is this profile?
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Equivalent Price Position
Shows whether safely comparable products are below, near or above the peer median unit price.
This is price-position intelligence, not sales, demand or market-share data.
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Therapeutic areas
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Drug classes
More specific classes derived from the canonical generic and preserved curated classifications.
Dosage forms
How MedInfoBase classifies the portfolio
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Deepest brand families
Unit-price positioning vs equivalent products
See where MEDICAIDS PAKISTAN PVT LTD is priced against the market
58 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Medicine portfolio
This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.
| Brand | Generic | Strength | Form | Pack | Registration | Source-listed price | Unit price | Price position |
|---|---|---|---|---|---|---|---|---|
| Advimol | Paracetamol | 500 mg | Tablet | 200's | 003216 | PKR 734.27 | PKR 3.67/tablet | 🔒 Pharma Pro |
| ALPAZOL | Omeprazole | 20 mg | Capsule | 14s | 032225 | PKR 249.16 | PKR 17.80/capsule | 🔒 Pharma Pro |
| ARTEBLAX | Artemether | 80 mg/mL | Injection | 6's | 053455 | PKR 1,224.25 | PKR 204.04/vial/unit | 🔒 Pharma Pro |
| ARTEBLAX | Artemether + Lumefantrine | 240 mg + 240 mg | Tablet | 8's | 061579 | PKR 546.35 | PKR 68.29/tablet | 🔒 Pharma Pro |
| Arteblax-L | Artemether + Lumefantrine | 20 mg + 120 mg | Tablet | 1 x 16's | 055714 | PKR 670.22 | PKR 41.89/tablet | 🔒 Pharma Pro |
| ARTEBLAX-L HD | Artemether + Lumefantrine | 80 mg + 480 mg | Tablet | 6's | 086786 | PKR 671.94 | PKR 111.99/tablet | 🔒 Pharma Pro |
| BIOXIM | Cefotaxime | 500 mg | Injection | Vial | 025695 | PKR 167.12 | PKR 167.12/vial/unit | 🔒 Pharma Pro |
| BIOXIM | Cefotaxime | 1 g | Injection | Vial | 026291 | PKR 229.24 | PKR 229.24/vial/unit | 🔒 Pharma Pro |
| BIOXIM | Cefotaxime | 250 mg | IM/IV injection | Vial | 026812 | PKR 110.89 | PKR 110.89/vial/unit | 🔒 Pharma Pro |
| CEFUROX | Cefuroxime | 250 mg | Injection | 5's + 5ml WFI | 024267 | PKR 335.97 | — | No comparator |
| CEFUROX | Cefuroxime | 750 mg | Injection | Vial + 5ml WFI | 024268 | PKR 240.86 | — | No comparator |
| CEFUROX | Cefuroxime | 1.5 g | Injection | Vial | 024269 | PKR 440.43 | PKR 440.43/vial/unit | 🔒 Pharma Pro |
| CEFUROX | Cefuroxime | 125 mg/5 mL | Suspension | 50 ml | 037460 | PKR 435.84 | PKR 8.72/mL | 🔒 Pharma Pro |
| CEFUROX | Cefuroxime | 250 mg | Tablet | 14's | 037461 | PKR 1,049.41 | PKR 74.96/tablet | 🔒 Pharma Pro |
| CEFUROX | Cefuroxime | 125 mg | Tablet | 14's | 037462 | PKR 537.71 | PKR 38.41/tablet | 🔒 Pharma Pro |
| CEFZIMED | Ceftazidime | 1 g | Injection | Vial | 067614 | PKR 479.57 | PKR 479.57/vial/unit | 🔒 Pharma Pro |
| CEFZIMED | Ceftazidime | 250 mg | Injection | Vial | 067615 | PKR 167.85 | PKR 167.85/vial/unit | 🔒 Pharma Pro |
| CEFZIMED | Ceftazidime | 500 mg | Injection | Vial | 073712 | PKR 255.32 | PKR 255.32/vial/unit | 🔒 Pharma Pro |
| CEVOCIP | Ciprofloxacin | 250 mg | Tablet | 10’s | 037455 | PKR 269.92 | PKR 26.99/tablet | 🔒 Pharma Pro |
| CEVOCIP | Ciprofloxacin | 500 mg | Tablet | 10’s | 037456 | PKR 539.84 | PKR 53.98/tablet | 🔒 Pharma Pro |
| CEVOCIP | Ciprofloxacin | 3 mg/mL | Ophthalmic solution | 5ml | 058067 | PKR 193.44 | PKR 38.69/mL | 🔒 Pharma Pro |
| CEVOCIP | Ciprofloxacin | 125 mg/5 mL | Suspension | 60ml | 104248 | PKR 222.36 | PKR 3.71/mL | 🔒 Pharma Pro |
| CEVOCIP | Ciprofloxacin | 250 mg/5 mL | Suspension | 60ml | 104249 | PKR 330.45 | PKR 5.51/mL | 🔒 Pharma Pro |
| ECOCEF | Ceftriaxone | 250 mg | IM injection | Vial + 3.5ml Lidocaine 1% | 024270 | PKR 244.34 | — | No comparator |
| ECOCEF | Ceftriaxone | 500 mg | IM injection | Vial + 3.5ml Lidocaine 1% | 024271 | PKR 419.45 | — | No comparator |
| ECOCEF | Ceftriaxone | 1 g | IM injection | Vial + 3.5ml Lidocaine 1% | 024272 | PKR 873.52 | — | No comparator |
| ECOCEF | Ceftriaxone | 250 mg | IV injection | Vial + 5ml Sterile Water | 028089 | PKR 244.34 | — | No comparator |
| ECOCEF | Ceftriaxone | 500 mg | IV injection | Vial + 5ml Sterile Water | 028090 | PKR 407.24 | — | No comparator |
| ECOCEF | Ceftriaxone | 1 g | IV injection | Vial + 5ml Sterile Water | 028091 | PKR 814.47 | — | No comparator |
| ENAMID | Ethionamide | 250 mg | Tablet | 30's | 058550 | PKR 824.66 | PKR 27.49/tablet | 🔒 Pharma Pro |
| ENRIST | Amikacin | 100 mg | Injection | 2ml | 025104 | PKR 169.16 | PKR 84.58/mL | 🔒 Pharma Pro |
| ENRIST | Amikacin | 250 mg | Injection | 2ml | 025105 | PKR 341.01 | PKR 170.51/mL | 🔒 Pharma Pro |
| ENRIST | Amikacin | 500 mg/2 mL | Injection | 1's | 026824 | PKR 536.33 | PKR 536.33/vial/unit | 🔒 Pharma Pro |
| FE-CHEW | Iron polymaltose complex | 100 mg elemental iron | Tablet | 10's | 039753 | PKR 164.27 | PKR 16.43/tablet | 🔒 Pharma Pro |
| FE-CHEW | Iron polymaltose complex | 100 mg | Tablet | 30's | 039753 | PKR 457.18 | PKR 15.24/tablet | 🔒 Pharma Pro |
| FE-CHEW | Iron | 50 mg/5 mL | Syrup | 60ml | 061798 | PKR 151.38 | PKR 2.52/mL | 🔒 Pharma Pro |
| FE-CHEW | Iron polymaltose complex + Folic acid | 100 mg + 0.35 mg | Tablet | 10's | 070569 | PKR 149.21 | PKR 14.92/tablet | 🔒 Pharma Pro |
| FE-CHEW FA | Iron polymaltose complex + Folic acid | 100 mg + 0.35 mg | Tablet | 30's | 070569 | PKR 429.73 | PKR 14.32/tablet | 🔒 Pharma Pro |
| GENIXIME | Cefixime | 100 mg/5 mL | Dry suspension | 30 ml | 028196 | PKR 330.39 | PKR 11.01/mL | 🔒 Pharma Pro |
| GENIXIME | Cefixime | 400 mg | Capsule | 5’s | 028915 | PKR 592.04 | PKR 118.41/capsule | 🔒 Pharma Pro |
| GENIXIME DS | Cefixime | 200 mg/5 mL | Dry suspension | 30ml | 067322 | PKR 404.32 | PKR 13.48/mL | 🔒 Pharma Pro |
| HYSOPAN | Hyoscine butylbromide | 10 mg | Tablet | 100's | 003213 | PKR 194.70 | PKR 1.95/tablet | No comparator |
| HYSOPAN | Hyoscine butylbromide | 20 mg | Injection | 1ml x 30's | 025694 | PKR 244.34 | PKR 8.14/mL | 🔒 Pharma Pro |
| IBUFIN | Ibuprofen | 200 mg | Tablet | 500’s | 006611 | PKR 938.44 | PKR 1.88/tablet | 🔒 Pharma Pro |
| IBUFIN | Ibuprofen | 400 mg | Tablet | 25 s | 006612 | PKR 76.26 | PKR 3.05/tablet | 🔒 Pharma Pro |
| IBUFIN | Ibuprofen | 400 mg | Tablet | 200’s | 006612 | PKR 684.29 | PKR 3.42/tablet | 🔒 Pharma Pro |
| Kraze | Azithromycin | 250 mg | Capsule | 1 x 6's | 031014 | PKR 285.07 | PKR 47.51/capsule | 🔒 Pharma Pro |
| Kraze | Azithromycin | 200 mg/5 mL | Suspension | 15 ml | 031015 | PKR 285.07 | PKR 19.00/mL | 🔒 Pharma Pro |
| Kraze | Azithromycin | 1% | Ophthalmic drops | 2.5ml | 082125 | PKR 270.81 | PKR 108.32/mL | No comparator |
| LEISH | Miltefosine | 50 mg | Capsule | 56's | 073486 | PKR 32,578.99 | PKR 581.77/capsule | 🔒 Pharma Pro |
All 32 MEDICAIDS PAKISTAN brands in Pakistan
- Advimol Paracetamol · 500 mg tablet
- ALPAZOL Omeprazole · 20 mg capsule
- ARTEBLAX Artemether + Lumefantrine, Artemether · 240 mg + 240 mg tablet, 80 mg/mL injection
- Arteblax-L Artemether + Lumefantrine · 20 mg + 120 mg tablet
- ARTEBLAX-L HD Artemether + Lumefantrine · 80 mg + 480 mg tablet
- BIOXIM Cefotaxime · 1 g injection, 250 mg injection, 500 mg injection
- CEFUROX Cefuroxime · 1.5 g injection, 125 mg tablet, 125 mg/5 mL suspension
- CEFZIMED Ceftazidime · 1 g injection, 250 mg injection, 500 mg injection
- CEVOCIP Ciprofloxacin · 125 mg/5 mL suspension, 250 mg tablet, 250 mg/5 mL suspension
- ECOCEF Ceftriaxone · 1 g injection, 250 mg injection, 500 mg injection
- ENAMID Ethionamide · 250 mg tablet
- ENRIST Amikacin · 100 mg injection, 250 mg injection, 500 mg/2 mL injection
- FE-CHEW Iron polymaltose complex, Iron polymaltose complex + Folic acid · 100 mg tablet, 100 mg + 0.35 mg tablet, 100 mg elemental iron tablet
- FE-CHEW FA Iron polymaltose complex + Folic acid · 100 mg + 0.35 mg tablet
- GENIXIME Cefixime · 100 mg/5 mL suspension, 400 mg capsule
- GENIXIME DS Cefixime · 200 mg/5 mL suspension
- HYSOPAN Hyoscine butylbromide · 10 mg tablet, 20 mg injection
- IBUFIN Ibuprofen · 200 mg tablet, 400 mg tablet
- Kraze Azithromycin · 1% drops, 200 mg/5 mL suspension, 250 mg capsule
- LEISH Miltefosine · 50 mg capsule
- LITHEN CR Lithium carbonate · 400 mg tablet
- LOPAMIDE Loperamide HCl · 2 mg capsule
- MEDIPRIL Enalapril · 5 mg tablet
- OXACOL Ofloxacin · 3 mg/mL solution
- Resdal Risperidone · 1 mg tablet, 2 mg tablet, 3 mg tablet
- RIBAZIN Ribavirin · 400 mg tablet
- Sterile water Water for Injection · 5 mL injection
- TEFNEL Levofloxacin · 250 mg tablet, 500 mg tablet
- TILOSAR Losartan · 50 mg tablet
- TIMOX Timolol · 5 mg/mL solution
- Trimex Sulfamethoxazole + Trimethoprim · 200 mg + 40 mg /5 mL suspension, 400 mg + 80 mg tablet
- Trimex Forte Sulfamethoxazole + Trimethoprim · 800 mg + 160 mg tablet
MEDICAIDS PAKISTAN: common questions
How many products does MEDICAIDS PAKISTAN have in Pakistan?
MEDICAIDS PAKISTAN PVT LTD has 70 registered medicine presentations in Pakistan, sold under 32 brands and covering 30 generic medicines.
What are the main brands of MEDICAIDS PAKISTAN?
By number of registered strengths and packs, its largest brands are Resdal (Risperidone), CEFUROX (Cefuroxime), ECOCEF (Ceftriaxone), CEVOCIP (Ciprofloxacin) and FE-CHEW (Iron polymaltose complex, Iron polymaltose complex + Folic acid). This is not a sales ranking.
Which therapy areas does MEDICAIDS PAKISTAN cover?
The most products are in Anti-infectives (45), CNS & mental health (8), Vitamins, minerals & nutrition (5), Pain & musculoskeletal (4) and Gastrointestinal & hepatology (4).
Where can I see MEDICAIDS PAKISTAN medicine prices?
Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
Cite this record
Manufacturer recordRecords change over time. Please cite the access date so readers can locate the version you used.